Cytokine Signalling Forum

CME Courses




« Return to Overview

Strategies for Improving Patient Outcomes in Rheumatoid Arthritis

Developed under the auspices of the University of Glasgow supported by an unrestricted educational grant from Pfizer Italia S.r.l.

This course is a 1-hour tutorial that has been designed as an educational resource for qualified rheumatologists of all levels of seniority. The field of rheumatology is constantly evolving in terms of available therapeutic options, and also management strategies which increasingly focus on the importance of a patient-centred approach. As such, it is important to understand how patient reported outcomes can play a role in target-oriented disease management. This course aims to address this by providing an understanding of these evolving management strategies in rheumatoid arthritis, the role of patient reported outcomes in these strategies, and the role of novel targeted small molecule therapies now and in the future.

By following this programme, members of the Cytokine Signalling Forum will be able to:

  • Understand the potential role of small molecule therapies in the management of rheumatoid arthritis
  • Understand the role of the patient perspective in assessing treatment response
  • The importance of patient reported outcomes to determine the impact of cytokine signalling pathway targeted therapies on quality of life
This course has been accredited by the EACCME.
Health Awards spring 2015

Module Presenter Video Questions
Introduction
Professor Laure Gossec image
Professor Laure Gossec

Professor of Rheumatology,
Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France

Laure Gossec, MD, PhD, is a Professor of Rheumatology in Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France. Professor Gossec earned her medical degree and her specialty training in rheumatology at Paris Descartes University and earned her PhD in clinical epidemiology from Montpellier University, Montpellier, France. Laure Gossec has a half-time clinical position where she mainly sees patients with inflammatory arthritis, and a half-time teaching and research position. In her teaching role, she has set up in her university a 20-hour module for medical students on patient–physician relationship and shared decision-making. In her research time, Professor Gossec’s interest is clinical research, in particular outcomes research and epidemiological research, with a focus on outcome measures for clinical trials and clinical practice, prediction of outcome and targeted treatments, in psoriatic arthritis (PsA), rheumatoid arthritis (RA) and spondyloarthritis. Professor Gossec is particularly interested in the patient’s perspective and patient-centered research and has successfully lead Europe-wide projects to develop scores to assess the impact of RA then PsA, under the aegis of the European League Against Rheumatism (EULAR).

In 2019, Professor Gossec was the lead investigator of an international study on outcomes in PsA (the Remission and Flares in PsA study), she led a EULAR taskforce on Big Data in rheumatology and coordinated with Professor Smolen (Austria) an update of the EULAR recommendations for the management of PsA.

Professor Gossec is Past-Chair of the Epidemiology standing committee of EULAR and is a founding member and past Chairperson of the Emerging EULAR Network (EMEUNET).

Professor Gossec has authored more than 350 peer-reviewed manuscripts published in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Rheumatology and Arthritis Research and Therapy.

Prof. Laure Gossec (Bio)
01:05
Evolving management strategies for rheumatoid arthritis
Professor Juan J. Gómez-Reino image
Professor Juan J. Gómez-Reino

Head of the Department of Rheumatology,
University Hospital, Santiago de Compostela, Spain

Professor Juan Gómez-Reino completed his medical and doctor of philosophy degrees at the University of Madrid, Spain and his postgraduate training in internal medicine and rheumatology at the New York State University, Stony Brook, USA. He was formerly chief of the Department of Research and Section of Rheumatology at Hospital Doce de Octubre, Madrid, Spain.

Professor Gómez-Reino’s main clinical interest is chronic inflammatory arthropathies, and his experimental research is in the genetics of complex diseases, the effect of neuropeptides on chondrocyte function, and arthritis in animal models. He has authored or co-authored a number of original articles and papers in the areas of rheumatoid arthritis, spondyloarthritis and other rheumatology-specific disorders.

Prof. Juan J. Gomez-Reino (Bio)
09:41 7
Patient perspectives in assessing treatment response in rheumatoid arthritis
Professor Laure Gossec image
Professor Laure Gossec

Professor of Rheumatology,
Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France

Laure Gossec, MD, PhD, is a Professor of Rheumatology in Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France. Professor Gossec earned her medical degree and her specialty training in rheumatology at Paris Descartes University and earned her PhD in clinical epidemiology from Montpellier University, Montpellier, France. Laure Gossec has a half-time clinical position where she mainly sees patients with inflammatory arthritis, and a half-time teaching and research position. In her teaching role, she has set up in her university a 20-hour module for medical students on patient–physician relationship and shared decision-making. In her research time, Professor Gossec’s interest is clinical research, in particular outcomes research and epidemiological research, with a focus on outcome measures for clinical trials and clinical practice, prediction of outcome and targeted treatments, in psoriatic arthritis (PsA), rheumatoid arthritis (RA) and spondyloarthritis. Professor Gossec is particularly interested in the patient’s perspective and patient-centered research and has successfully lead Europe-wide projects to develop scores to assess the impact of RA then PsA, under the aegis of the European League Against Rheumatism (EULAR).

In 2019, Professor Gossec was the lead investigator of an international study on outcomes in PsA (the Remission and Flares in PsA study), she led a EULAR taskforce on Big Data in rheumatology and coordinated with Professor Smolen (Austria) an update of the EULAR recommendations for the management of PsA.

Professor Gossec is Past-Chair of the Epidemiology standing committee of EULAR and is a founding member and past Chairperson of the Emerging EULAR Network (EMEUNET).

Professor Gossec has authored more than 350 peer-reviewed manuscripts published in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Rheumatology and Arthritis Research and Therapy.

Prof. Laure Gossec (Bio)
19:00 13
Evaluation 4

Date of preparation: December 2013